These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 23542166

  • 1. Structure-activity relationship of 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole analogues as 5-HT(6) receptor agonists.
    Mattsson C, Svensson P, Boettcher H, Sonesson C.
    Eur J Med Chem; 2013 May; 63():578-88. PubMed ID: 23542166
    [Abstract] [Full Text] [Related]

  • 2. 2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists.
    Mattsson C, Sonesson C, Sandahl A, Greiner HE, Gassen M, Plaschke J, Leibrock J, Böttcher H.
    Bioorg Med Chem Lett; 2005 Oct 01; 15(19):4230-4. PubMed ID: 16055331
    [Abstract] [Full Text] [Related]

  • 3. N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists.
    Cole DC, Ellingboe JW, Lennox WJ, Mazandarani H, Smith DL, Stock JR, Zhang G, Zhou P, Schechter LE.
    Bioorg Med Chem Lett; 2005 Jan 17; 15(2):379-83. PubMed ID: 15603958
    [Abstract] [Full Text] [Related]

  • 4. Novel 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 agonists and antagonists.
    Elokdah H, Li D, McFarlane G, Bernotas RC, Robichaud AJ, Magolda RL, Zhang GM, Smith D, Schechter LE.
    Bioorg Med Chem; 2007 Sep 15; 15(18):6208-26. PubMed ID: 17624788
    [Abstract] [Full Text] [Related]

  • 5. Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats.
    Jastrzębska-Więsek M, Siwek A, Partyka A, Antkiewicz-Michaluk L, Michaluk J, Romańska I, Kołaczkowski M, Wesołowska A.
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug 15; 389(8):839-49. PubMed ID: 27106213
    [Abstract] [Full Text] [Related]

  • 6. Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.
    Nirogi R, Dwarampudi A, Kambhampati R, Bhatta V, Kota L, Shinde A, Badange R, Jayarajan P, Bhyrapuneni G, Dubey PK.
    Bioorg Med Chem Lett; 2011 Aug 01; 21(15):4577-80. PubMed ID: 21724392
    [Abstract] [Full Text] [Related]

  • 7. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.
    Vacher B, Bonnaud B, Funes P, Jubault N, Koek W, Assié MB, Cosi C, Kleven M.
    J Med Chem; 1999 May 06; 42(9):1648-60. PubMed ID: 10229633
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and biological evaluation of novel 3-(5-substituted-1H-indol-3-yl)pyrrolidine-2,5-dione derivatives with a dual affinity for serotonin 5-HT1A receptor and SERT.
    Wróbel MZ, Chodkowski A, Dawidowski M, Siwek A, Stachowicz K, Szewczyk B, Nowak G, Satała G, Bojarski AJ, Turło J.
    Bioorg Chem; 2023 Dec 06; 141():106903. PubMed ID: 37827015
    [Abstract] [Full Text] [Related]

  • 9. Partial agonist efficacy of EMD386088, a 5-HT6 receptor ligand, in functional in vitro assays.
    Jastrzębska-Więsek M, Siwek A, Kazek G, Nawieśniak B, Partyka A, Marcinkowska M, Kołaczkowski M, Wesołowska A.
    Pharmacol Rep; 2013 Dec 06; 65(4):998-1005. PubMed ID: 24145094
    [Abstract] [Full Text] [Related]

  • 10. Serotonin 5-HT2 receptor, dopamine D2 receptor, and alpha 1 adrenoceptor antagonists. Conformationally flexible analogues of the atypical antipsychotic sertindole.
    Andersen K, Liljefors T, Hyttel J, Perregaard J.
    J Med Chem; 1996 Sep 13; 39(19):3723-38. PubMed ID: 8809161
    [Abstract] [Full Text] [Related]

  • 11. Indolebutylamines as selective 5-HT(1A) agonists.
    Heinrich T, Böttcher H, Bartoszyk GD, Greiner HE, Seyfried CA, Van Amsterdam C.
    J Med Chem; 2004 Sep 09; 47(19):4677-83. PubMed ID: 15341483
    [Abstract] [Full Text] [Related]

  • 12. 1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-indoles as novel 5-HT6 receptor ligands.
    Bernotas R, Lenicek S, Antane S, Zhang GM, Smith D, Coupet J, Harrison B, Schechter LE.
    Bioorg Med Chem Lett; 2004 Nov 15; 14(22):5499-502. PubMed ID: 15482912
    [Abstract] [Full Text] [Related]

  • 13. Discovery of 5-arylsulfonamido-3-(pyrrolidin-2-ylmethyl)-1H-indole derivatives as potent, selective 5-HT6 receptor agonists and antagonists.
    Cole DC, Lennox WJ, Lombardi S, Ellingboe JW, Bernotas RC, Tawa GJ, Mazandarani H, Smith DL, Zhang G, Coupet J, Schechter LE.
    J Med Chem; 2005 Jan 27; 48(2):353-6. PubMed ID: 15658848
    [Abstract] [Full Text] [Related]

  • 14. Novel potent 5-HT(1F) receptor agonists: structure-activity studies of a series of substituted N-[3-(1-methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]amides.
    Filla SA, Mathes BM, Johnson KW, Phebus LA, Cohen ML, Nelson DL, Zgombick JM, Erickson JA, Schenck KW, Wainscott DB, Branchek TA, Schaus JM.
    J Med Chem; 2003 Jul 03; 46(14):3060-71. PubMed ID: 12825944
    [Abstract] [Full Text] [Related]

  • 15. Design and synthesis of novel series of 5-HT6 receptor ligands having indole, a central aromatic core and 1-amino-4 methyl piperazine as a positive ionizable group.
    Hayat F, Cho S, Rhim H, Indu Viswanath AN, Pae AN, Lee JY, Choo DJ, Choo HY.
    Bioorg Med Chem; 2013 Sep 01; 21(17):5573-82. PubMed ID: 23810425
    [Abstract] [Full Text] [Related]

  • 16. N-Arylsulfonylindole derivatives as serotonin 5-HT(6) receptor ligands.
    Russell MG, Baker RJ, Barden L, Beer MS, Bristow L, Broughton HB, Knowles M, McAllister G, Patel S, Castro JL.
    J Med Chem; 2001 Nov 08; 44(23):3881-95. PubMed ID: 11689074
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N₁-arylsulfonyl indole derivatives as 5-HT₆ receptor ligands.
    Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M.
    Bioorg Med Chem Lett; 2012 Dec 15; 22(24):7431-5. PubMed ID: 23141912
    [Abstract] [Full Text] [Related]

  • 18. 5-HT6 receptor ligands, EMD386088 and SB258585, differentially regulate 5-HT6 receptor-independent events.
    Yun HM, Rhim H.
    Toxicol In Vitro; 2011 Dec 15; 25(8):2035-40. PubMed ID: 21864673
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of selective 5-HT6 receptor ligands determined by monitoring 5-HT6 receptor-mediated cAMP signaling pathways.
    Romero G, Sánchez E, Pujol M, Pérez P, Codony X, Holenz J, Buschmann H, Pauwels PJ.
    Br J Pharmacol; 2006 Aug 15; 148(8):1133-43. PubMed ID: 16865095
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and biological evaluation of novel pyrrolidine-2,5-dione derivatives as potential antidepressant agents. Part 1.
    Wróbel MZ, Chodkowski A, Herold F, Gomółka A, Kleps J, Mazurek AP, Pluciński F, Mazurek A, Nowak G, Siwek A, Stachowicz K, Sławińska A, Wolak M, Szewczyk B, Satała G, Bojarski AJ, Turło J.
    Eur J Med Chem; 2013 May 15; 63():484-500. PubMed ID: 23524160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.